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A model of autosomal recessive Alport syndrome in English
cocker spaniel dogs.
Background. Dogs with naturally occurring genetic disorders of
basement membrane (type IV) collagen may serve as animal
models of Alport syndrome.
Methods. An autosomal recessive form of progressive heredi-
tary nephritis (HN) was studied in 10 affected, 3 obligate carrier,
and 4 unaffected English cocker spaniel (ECS) dogs. Clinical,
pathological, and ultrastructural features of the disease were
characterized. Expression of basement membrane (BM) proteins
was examined with an immunohistochemical technique using
monospecific antibodies.
Results. Affected dogs had proteinuria and juvenile-onset
chronic renal failure. Glomerular basement membrane (GBM)
thickening and multilamellation typical of HN were observed in
all renal specimens obtained from proteinuric dogs, and severity
of GBM ultrastructural abnormalities varied with the clinical
stage of disease. Expression of a3(IV) and a4(IV) chains was
totally absent in the kidney of affected dogs. Expression of a5(IV)
and a6(IV) chains was normal in Bowman’s capsule, collecting
tubular BM and epidermal BM of affected dogs. The a5(IV)
chain was not expressed in distal tubular BM of affected dogs.
Expression of a5(IV) chains was markedly reduced but not
absent, and expression of a6(IV) chains was present in GBM of
affected dogs. Expression of a1-a2(IV) chains in GBM of affected
dogs was increased. Features of obligate carriers were similar to
those of unaffected dogs.
Conclusions. We conclude that HN in ECS dogs is a naturally
occurring animal model of autosomal recessive Alport syndrome.
However, it differs from human disease in the persistence of
a5(IV) chains in GBM and in the appearance of a6(IV) chains in
GBM.
Hereditary nephritis (HN) refers to a group of genetic
disorders of basement membrane (type IV) collagen that
cause progressive glomerular disease [1–3]. In humans with
Alport syndrome (AS), the nephropathy is frequently asso-
ciated with sensorineural hearing loss and ocular abnormal-
ities. Distinctive ultrastructural changes in glomerular base-
ment membranes (GBM) of affected individuals is a
prominent characteristic of these disorders [1–3].
In humans AS usually is X-linked, resulting from muta-
tions in the COL4A5 gene, which encodes the a5 chain of
type IV collagen [1, 4]. Some families have an autosomal
recessive form of AS, due to mutations in the COL4A3 or
COL4A4 gene on chromosome 2, that affect the a3(IV) or
a4(IV) chain [5–8]. Rare families have AS with an auto-
somal dominant pattern of inheritance [9]. Jefferson et al
have mapped autosomal dominant AS to the region of
COL4A3 and COL4A4 in a single family, but have yet to
identify a specific mutation [10].
Naturally occurring diseases that are animal models for
AS have been identified in dogs. An X-linked form of HN
in a family of Samoyed dogs has been thoroughly charac-
terized [11–16]. The causative mutation, located in exon 35
of the COL4A5 gene, is a single nucleotide substitution
that produces a premature stop codon [17]. Additionally,
autosomal dominant HN has been described in bull terrier
dogs, but the causative mutation is unknown [18].
We have identified an autosomal recessive form of HN in
English cocker spaniel (ECS) dogs. Initially, ultrastructural
GBM lesions similar to those of HN were identified in
several juvenile ECS dogs that had advanced renal failure
[19]. Subsequently, repeated matings of the parents of
affected dogs produced additional affected dogs [20]. Oc-
currence of an inherited nephropathy in ECS dogs has been
recognized for many years; however, previous investigators
had not clearly established that the disease was a form of
HN [21–25]. Nonetheless, studies had shown that the
disease was a rapidly progressive glomerular disorder that
was inherited in an autosomal recessive fashion [26, 27].
Pedigrees of affected ECS dogs that we studied also were
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compatible with autosomal recessive transmission of the
disease [20].
Immunohistochemical techniques have been used to
study distribution of collagen a(IV) chains in basement
membranes of humans with AS, dogs with HN, and trans-
genic mice with COL4A3 mutations. Expression of a3(IV),
a4(IV), and a5(IV) usually is absent in the GBM of men
with X-linked AS, while women who are heterozygous for
X-linked AS mutations frequently lack these chains in
portions of their GBM [28–31]. In people with autosomal
recessive AS, a3(IV), a4(IV), and a5(IV) chains usually
are lacking in GBM; however, the a5(IV) chain is present
in other basement membranes, for example, Bowman’s
capsule, collecting tubular basement membrane, and epi-
dermal basement membrane [32]. Transgenic COL4A3
mutant mice lack a3(IV), a4(IV) and a5(IV) chains in
their GBM and tubular basement membranes [33, 34].
Human sera from patients with Goodpasture disease have
been used to study X-linked HN in Samoyed dogs. These
sera, which contain antibodies reacting mainly with a3(IV)
chains, bind to normal dog GBM but not to the GBM of
affected males [14]. Segmental GBM staining is seen in
young heterozygous females, but staining becomes global as
the dogs grow older [16]. In bull terrier dogs with autoso-
mal dominant HN, renal expression of a3(IV) and a5(IV)
chains appeared normal using monospecific antibodies
[18].
This article describes the clinical, ultrastructural and
immunohistochemical features of autosomal recessive HN
in ECS dogs. Monospecific antibodies were used to deter-
mine the distribution of a(IV) chains in renal and epider-
mal basement membranes of affected dogs.
METHODS
Dogs
Subjects were 17 ECS dogs that were selected in several
ways (Table 1). Seven dogs (numbers 1 to 7) were identified
when they developed juvenile-onset chronic renal failure.
As described in a previous clinical report, which included
four of these animals, such dogs were found be HN-
affected by postmortem examinations that revealed char-
acteristic ultrastructural GBM changes [19]. Four dogs
(numbers 8 to 10, and 14) were offspring from repeat
matings of dogs that had produced an affected dog in a
previous litter. Three of these four dogs also were affected
[20]. Three dogs (numbers 11 to 13) were obligate HN
carriers, identified by having at least one offspring in which
HN had been diagnosed. Three dogs (numbers 15 to 17)
were healthy animals that served as controls.
Each affected dog met two criteria for diagnosis of HN.
First, the kidney disease exhibited clinicopathologic fea-
tures identical to those described for the familial nephrop-
athy that has been recognized in ECS dogs for many years.
Second, examination with transmission electron micros-
copy (TEM) demonstrated characteristic abnormalities of
GBM ultrastructure. Every dog with the clinicopathologic
features of familial nephropathy that was examined with
TEM had similar GBM changes.
Table 1. English cocker spaniel dogs studied
Dog no. Family
HN
phenotype Gender
Age at
initial
exam
Age at
last
exam
Proteinuria
Renal
failure
TEM
thick
GBMmonths
1 A Affected M 10 11 Pos Pos Pos
2 B Affected M — 27 Pos Pos Pos
3 C Affected M 15 22 Pos Pos Pos
4 D Affected F — 13 Pos Pos Pos
5 E Affected M 9 9 Pos Pos Pos
6 F Affected M — 10 Pos Pos Pos
7 G Affected F — 15 Pos Pos Pos
8 A Affected M 3 8 Pos Pos Pos
9 H Affected F 3 13 Pos Pos Pos
10 H Affected F 3 17 Pos Pos Pos
11 A Carrier M — 88 Neg Neg ND
12 A Carrier F 59 73 Neg Neg Neg
13 I Carrier F 102 104 Neg Neg Neg
14 H Unaffected M 3 50 Neg Neg Neg
15 J Normal M — 19 Neg Neg Neg
16 K Normal F — 76 Neg Neg Neg
17 L Normal F — 9 Neg Neg Neg
Dogs 1 and 8 were siblings but not littermates; dogs 11 and 12 were parents of dogs 1 and 8. Dogs 9, 10, and 14 were littermate siblings. Abbreviations
are: HN, hereditary nephritis; TEM, transmission electron microscopy; Affected, HN diagnosis based on clinicopathologic features and TEM findings;
Carrier, parent of an HN-affected dog; Unaffected, healthy dog from HN-carrier parents; could be a carrier or a normal dog; Normal, kindred contains
no HN-affected dogs, and little chance of being a HN-carrier; ND, not determined.
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Clinical evaluations
Eight dogs were evaluated once, and nine dogs were
evaluated on 2 to 26 occasions. Five dogs with multiple
evaluations were examined two to six times at irregular
intervals. The other four dogs were evaluated monthly
beginning when they were three months old and continuing
until they developed renal failure and were euthanatized or
became two years old and were still healthy [20].
Clinical evaluations were performed by conventional
methods. Histories were reviewed, and complete physical
examinations were performed. Renal ultrasonography was
performed on 29 occasions in 15 dogs using an Ultramark
4 (Advanced Technology Laboratories) unit with a 7.5-
MHz mechanical sector transducer. In seven dogs, samples
of renal cortex were obtained on 11 occasions using a
percutaneous, ultrasound-guided biopsy technique [20]. In
two other dogs, a wedge biopsy specimen of renal cortex
was obtained during a celiotomy. Systemic blood pressures
were determined in nine dogs on 13 occasions using a
Dinamap Model 8300 (Critikon) oscillometric blood pres-
sure monitor [35, 36]. For each blood pressure determina-
tion, five sequential Dinamap readings were averaged, and
hypertension was present if systolic pressure exceeded 180
mm Hg or diastolic pressure exceeded 100 mm Hg. Hearing
was tested 14 times in eight dogs by evaluating brainstem
auditory-evoked responses (BAER) to high intensity (that
is, 80 to 100 dB) clicks in each ear using a standard protocol
[37]. The eyes of eight dogs were examined on 16 occasions
by a veterinary ophthalmologist using a slit lamp biomicro-
scope and an indirect ophthalmoscope following dilation of
the pupils.
Urinalyses, complete blood counts, and serum biochem-
istry tests were performed using standard methods. Eighty
urine specimens obtained from 17 dogs were evaluated.
Urine protein:creatinine ratio (UPC) usually was deter-
mined, and for UPC, urine protein concentration was
determined by a turbidometric method on a Discrete
Clinical Analyzer (Dupont) and urine creatinine concen-
tration was measured by the Ektachem Creatinine (single-
slide method) two-point rate enzymatic test (Kodak).
When three months of age, two of four dogs had slightly
increased UPC values (up to 1.6) that did not persist as the
dogs grew older [20]. Therefore, UPC $ 2 defined exis-
tence of proteinuria in this study. Hematuria was present if
the Multistix (Ames) test result for blood was “small” or
greater, or if as many as five erythrocytes were seen in a
light microscopic field having a magnification of 3400.
Association of hematuria with proteinuria was examined
using a Fisher Exact Test (Statistix 4.1; Analytical Software,
Tallahassee, FL, USA). Complete blood cell counts were
performed on 47 specimens from 15 dogs. Platelet number
was determined in 43 specimens from 13 dogs, but platelet
size was not measured. A panel of serum chemistry tests
was performed on 51 samples from 15 dogs.
Postmortem evaluations
Nine of 10 affected dogs were euthanized and necropsied
immediately thereafter at the Texas Veterinary Medical
Center. One affected dog was euthanatized and necropsied
in another state, and the dog’s kidneys were sent to Texas
for evaluation.
Histological and ultrastructural examination of the
kidneys
Histological examination. Kidney specimens obtained
from 16 dogs were examined by light microscopy, and in
three affected and one unaffected dogs, a series of renal
specimens (2 to 4 from each dog) was examined. Tissues
were fixed in 10% buffered formalin and embedded in
paraffin. Sections approximately 3 mm thick were prepared
with hematoxylin and eosin (H&E), periodic-acid schiff
(PAS), Gomori’s methenamine silver (GMS) and tri-
chrome stains for examination.
Ultrastructural examination. Renal cortex from 16 dogs,
including serial specimens from four dogs, were fixed in
Karnovsky’s fixative, 4% paraformaldehyde and 6.25%
glutaraldehyde in 0.1 M sodium cacodylate buffer, post-
fixed in 1% osmium tetroxide and embedded in EM BED
812 and Araldite 502 (Electron Microscopy Sciences, Fort
Washington, PA, USA). Thin sections were cut on a Sovrall
Ultra Microtome MT 2, supported on 300 mesh copper
grids, and stained with saturated uranyl acetate and Sato’s
lead citrate. Grids were examined in a Zeiss 10 C transmis-
sion electron microscope.
Immunohistochemical procedures
Tissues. Kidney specimens were obtained by biopsy or at
necropsy from 12 dogs. Skin specimens also were obtained
by biopsy or at necropsy from two affected and two normal
dogs.
Antibodies. The primary antibodies used in this study are
listed in Table 2. All secondary antibodies were affinity-
Table 2. Primary antibodies used in immunohistochemical studies
Name Type Specificity
Reference or
source
MAb M3F7 Monoclonal a1/a2(IV) helix [38]
MAb 102 Monoclonal a1(IV) NC1 [39]
MAb A2 Monoclonal a3(IV) NC1 [40]
Anti-a4(IV) Polyclonal a4(IV) NC1 [41]
MAb A7 Monoclonal a5(IV) NC1 [42]
MAb H52 Monoclonal a5(IV) NC1 [43]
MAb B66 Monoclonal a6(IV) NC1 a
MAb C4 Monoclonal Laminin b2 Hybridoma Bank,
Iowa City, IA
MAb B1 Monoclonal Laminin b1 Chemicon,
Temecula, CA
MAb 2E8 Monoclonal Laminin g1 Hybridoma Bank,
Iowa City, IA
a MAb B66 is a mouse monoclonal antibody raised against bovine
a6(IV) NC1 by methods described in reference 44. This antibody cross-
reacts with human and dog a6(IV) chains.
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purified fluorescein isothiocyanate-(FITC)-conjugated im-
munoglobulins, including goat anti-rabbit IgG (Biosource,
Camarillo, CA, USA), goat anti-rat IgG (Pel-Freeze, Rog-
ers, AR, USA), and goat anti-mouse IgG (Cappel,
Durham, NC, USA). All secondary antibodies were ab-
sorbed with normal canine serum.
Indirect immunofluorescence. Most tissues were embed-
ded in Tissue-Tek OCT (Miles) and snap-frozen in liquid
nitrogen, but two skin biopsy specimens were snap-frozen
in isopentane that was precooled in liquid nitrogen. Tissues
were sectioned at 4 mm in a Lipshaw cryostat in a constant
temperature (25°C) and humidity (30%) room, and fixed
for 10 minutes in acetone (for nondenatured sections) or
ethanol (for sections to be denatured). After washing in
fresh buffer (0.01 M PBS, pH 7.4), slides were incubated in
a moist chamber with the appropriate dilution of primary
antibodies. Incubation with FITC secondary antibodies was
then performed. Slides that were to be incubated with
anti-a4(IV), MAb A7 or MAb H52 were pretreated with
0.1 M glycine, 6 M urea, pH 3.5 for 10 minutes, then rinsed
with distilled water and processed for the immunolabeling
as described. To retard fluorescence quenching, a mounting
media containing p-phenylenediamine was used. Labeling
was examined with an epifluorescence microscope with
appropriate filters (Carl Zeiss, Inc., Oberkochen, Germa-
ny), and fluorescence was graded 0 to 31 by two observers.
Tissue sections directly incubated with secondary antibod-
ies served as controls, and negative results were obtained in
all instances.
RESULTS
Clinical features
Affected dogs were 8 to 27 months (median, 13 months)
of age when euthanized (Table 1; dogs 1 to 10). Two dogs
were euthanized shortly after azotemia first occurred; the
nephropathy in these dogs was not permitted to reach end
stage. The other eight affected dogs were euthanized at or
near the end stage of their disease.
Early clinical features of HN were characterized in three
affected dogs that were repeatedly evaluated beginning
when they were three months old. At three to four months
of age, the dogs appeared healthy. They exhibited good
urine concentrating ability (urine specific gravity . 1.035),
and proteinuria was absent (UPC , 2.0). Proteinuria,
which began at five to eight months of age, was the first
abnormality detected in affected dogs. A similar pattern of
abnormalities was observed in affected dogs after they
developed proteinuria, but the rate of subsequent change
varied among the dogs. Growth rate decreased (data not
shown), while the urine concentrating ability gradually
diminished (data not shown), and concentrations of BUN
and serum creatinine progressively increased (data not
shown). Intervals from onset of proteinuria to development
of azotemia (serum creatinine . 2.0 mg/dl) were two to
nine months.
Two dogs that were later found to have HN exhibited
proteinuria that was substantial but transient and associ-
ated with a brief episode of self-limiting, nonrenal illness.
The proteinuria promptly resolved when the dogs recov-
ered from their illnesses, and urine specimens (2 from each
dog) that were evaluated during the next two months did
not contain excess protein. Clinical signs were not observed
in conjunction with the subsequent onset of persistent
proteinuria in these dogs. Indeed, onset of persistent
proteinuria was not associated with clinical signs in any
affected dog.
Excess protein was observed in 40 of 80 urine specimens,
and every proteinuric sample was obtained from an af-
fected dog. The 40 specimens that lacked proteinuria
included all 30 samples obtained from seven dogs that did
not have HN and 10 specimens obtained from four affected
dogs before their onsets of persistent proteinuria.
Values for UPC determined in 35 specimens obtained
from 9 of 10 affected dogs with persistent proteinuria were
2.0 to 13.2 (median, 8.4). The highest UPC value observed
in each affected dog was 7.0 to 13.2 (median, 11.1).
Thirty-six specimens obtained from dogs that did not have
HN (26 specimens), as well as from four affected dogs
during periods before their onsets of proteinuria (10 spec-
imens), had UPC values that were 0.05 to 1.6 (median,
0.31).
Hematuria was observed in 5 (12.5%) of 40 specimens
obtained from dogs that were not exhibiting proteinuria,
and in 19 (47.5%) of 40 specimens from affected dogs with
proteinuria. Hematuria was associated (P 5 0.001) with
proteinuria (Table 3).
Results of routine hematologic tests were within normal
limits for specimens obtained from dogs that did not have
renal failure (serum creatinine , 2.0 mg/dl). However,
evaluations of affected dogs shortly before euthanasia
invariably demonstrated anemia (hematocrit 11 to 33%;
median, 20%; reference range, 37 to 55%). Three dogs that
were severely uremic when they were evaluated had mild
thrombocytopenia (125,000 to 192,000 platelets/ml; refer-
ence range, 200,000 to 500,000 platelets/ml), but platelet
numbers were otherwise normal.
Serum chemistry test results were abnormal only in
affected dogs. Eight of 10 affected dogs had a reduced
serum albumin concentration on at least one occasion. The
Table 3. Hematuria in English cocker spaniel dogs with hereditary
nephritis
Number of specimens
Hematuric Non-hematuric Total
Proteinuric 19 (24%) 21 (26%) 40 (50%)
Non-proteinuric 5 (6%) 35 (44%) 40 (50%)
Total 24 (30%) 56 (70%) 80 (100%)
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lowest serum albumin value observed in each dog was 1.8 to
3.0 mg/dl (median, 2.2 mg/dl; reference range, 2.4 to 3.6
mg/dl). Nine of 10 affected dogs had an increased serum
cholesterol concentration on at least one occasion, and the
highest cholesterol value observed in each dog was 218 to
395 mg/dl (median, 336 mg/dl; reference range, 120 to 247
mg/dl). Final evaluations of the affected dogs demonstrated
varying degrees of azotemia (serum creatinine concentra-
tions 2.1 to 12.8 mg/dl; median, 5.4 mg/dl; reference range,
0.3 to 2.0 mg/dl), increased serum phosphorus concentra-
tions (7.6 to 25.2 mg/dl; median, 15.8 mg/dl; reference
range, 2.9 to 6.2 mg/dl) and reduced serum total CO2
concentrations (5 to 20 mmol/liter; median, 16 mmol/liter;
reference range, 21 to 28 mmol/liter).
Blood pressure measurements were obtained from seven
of ten affected dogs, one of three obligate carriers, and the
unaffected dog. Hypertension was not detected in any dog.
Abnormalities of kidney size, architecture or relative
echogenicity were not detected by sonography in affected
dogs that were not azotemic. Dogs with renal failure had
hyperechoic renal cortices. Ultrasound-guided kidney bi-
opsy procedures were performed without apparent compli-
cation.
Signs suggestive of impaired hearing were not reported
by the owners of any dog, and dogs appeared to respond
normally to sound during their examinations. Hearing, as
evaluated by BAER tests, was normal when evaluated in six
of ten affected dogs, one of three obligate carriers, and the
unaffected dog. Ocular abnormalities similar to lesions
associated with Alport syndrome in humans were not
observed in the eight dogs that were examined thoroughly.
Postmortem examination of kidney
Necropsies were performed on dogs with renal failure.
Kidneys were uniformly reduced in size, overly firm, and
had fine pitting of their cortical surfaces. Renal capsules
stripped easily. The kidneys were pale tannish-brown, the
cortices were uniformly thinned, and the cortical to med-
ullary ratios varied from 1:2.5 to 1:3 (normal 1:2).
Histological examination of kidney
Light microscopic lesions in affected dogs varied greatly
depending on the stage of disease progression. The earliest
lesion, which was observed in kidneys of six-month-old
dogs, was focal mesangial expansion (Fig. 1A). Expanded
mesangial areas stained weakly positive as collagen with
Masson’s trichrome, but did not react with either the PAS
or GMS techniques and was not visible through crossed-
polars using Congo Red dye. Rare glomeruli were con-
tracted with adhesions to Bowman’s capsule. Glomerular
capillary basement membranes were segmentally thickened
with both GMS and PAS, and the thickened areas had a
“moth-eaten” appearance (Fig. 1B). The interstitium adja-
cent to affected glomeruli sometimes had infiltrates of
lymphoid cells and mononuclear phagocytes.
Five dogs that were necropsied at 9 to 17 months of age
had multifocal cortical disease distributed in a radial pat-
tern extending from the capsule to the corticomedullary
junction with alternating zones of diseased and more
normal parenchyma. In affected cortical tissue, glomeruli
showed a range of lesions from mild to severe. Mild lesions
consisted of segmental thickening of the capillary basement
membranes and focal mesangial expansion similar to that
described in six-month-old dogs. Moderate lesions were
those of segmental glomerular fibrosis with adhesions to
Bowman’s capsule and some early periglomerular fibrosis.
Severe lesions consisted of complete glomerular sclerosis.
In one dog, a majority of the remaining glomeruli were
atrophic and contracted with cystic dilation of Bowman’s
capsule.
Fig. 1. (A) Light microscopic appearance of a kidney biopsy from a 6-month-old affected dog (no. 8) with proteinuria (Masson’s trichrome, 3600).
Multiple foci of mesangial expansion are visible in the glomerulus (arrows). (B) Light microscopic appearance of a kidney biopsy from a 6-month-old
affected dog (no. 9) with proteinuria (Masson’s trichrome, 3400). Multiple capillary walls within the glomerulus are thickened and have a “moth-eaten”
appearance (arrows).
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The interstitium around diseased glomeruli was fibrotic
and there were multifocal accumulations of lymphocytes
and macrophages located around glomeruli and tubules.
The latter displayed degenerative changes resulting in
epithelial necrosis, tubular collapse, and fibrosis or tubular
dilation with accumulation of proteinaceous material.
Four dogs that were necropsied at 8 to 27 months of age
had severe microscopic renal lesions similar to those de-
scribed above, but the radial pattern of distribution was no
longer visible. The lesions were homogeneously diffuse
throughout the cortex, and there was mild to moderate
medullary interstitial fibrosis. Ninety percent or more of
glomeruli in any single section had lesions as described
previously. However, more than 50% of glomeruli were
sclerotic. Cystic glomerular atrophy was not prominent in
these dogs. The magnitude of cellular inflammation was
more pronounced in these dogs, as was the incidence of
dilated tubules filled with proteinaceous material. There
was also variable renal tubular, glomerular, and arterial
intimal mineralization.
The light microscopic appearance of kidney biopsy spec-
imens from the remaining dogs was normal.
Ultrastructural examination kidney
A range of ultrastructural changes were observed in the
GBM of affected dogs examined at different stages of
disease progression. In six-month-old dogs, samples ob-
tained about one month after onset of persistent protein-
uria had both thinning and thickening of the GBM (Fig. 2
A–C). Thickened GBM often exhibited bilaminar splitting
and its epithelial aspect had an irregular contour. Focal
fusion of visceral epithelial cell foot processes was associ-
ated with GBM thickening. These GBM abnormalities
were diffuse but mild compared with later stages of pro-
gression. Subsequent specimens from these dogs, obtained
about one month after onset of azotemia, exhibited multi-
lamellation and greater thickening of the GBM with diffuse
fusion of visceral epithelial cell foot processes. Especially in
its thickest segments, the GBM was composed of a disor-
ganized network of membranous strands that frequently
enclosed electron-lucent areas. Spherical electron-dense
structures were sometimes seen between the lamellations in
the GBM. In dogs nearing the end stage of their disease,
marked GBM thickening and multilamellation was exten-
sive (Fig. 2D).
Fig. 2. (A) Electron micrograph of glomerular basement membrane (GBM) from an unaffected 6-month-old dog (no. 13) showing normal thickness
and ultrastructure (315,000). (B) Electron micrograph of GBM from an affected 6-month-old dog (no. 7) with proteinuria (315,000). A segment of
the GBM is thinner than normal (arrows). (C) Electron micrograph of GBM from another area of the same specimen shown in panel B (315,000). The
slightly thickened GBM exhibits bilaminar splitting and its epithelial aspect has an irregular contour. (D) Electron micrograph of GBM from an affected
15-month-old dog (no. 7) with renal failure showing marked thickening and multilamellation of the GBM (315,000).
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In other dogs that were examined, GBM ultrastructure
appeared normal.
Immunohistochemical examinations
Renal specimens. Similar patterns of immunofluores-
cence staining were observed in kidney from normal dogs,
the unaffected dog, and obligate carriers (Table 4). The
a1-a2(IV) chains were distributed in all basement mem-
branes (BM) (Figs. 3A and 4A). Labeling for a3-a4(IV)
chains was observed only in GBM and the BM of distal
tubules (Figs. 3C, 3E, 4C, and 4E). The a5(IV) chain was
co-distributed with a3-a4(IV) chains in GBM and distal
tubular BM (Figs. 3G and 4G), but labeling for a5(IV)
chains also was observed in BM of Bowman’s capsule (Fig.
3G) and collecting tubules and in the walls of renal
arterioles (not shown). Variable labeling for a6(IV) chains
was observed in GBM. Adolescent dogs had no GBM
labeling for a6(IV) (Fig. 5A), but older dogs had segmental
(Fig. 5B) or diffuse (Fig. 5C) GBM labeling for a6(IV)
chains. In the unaffected dog, for example, GBM labeling
for the a6(IV) chain was absent at 6 and 13 months of age
but present at 30 and 50 months of age. The a6(IV) chain
also was consistently co-distributed with the a5(IV) chain
in BM of Bowman’s capsule (Figs. 5 A–C), in collecting
tubular BM, and in the walls of renal arterioles (not
shown). Labeling for each a(IV) chain in tubular BM
generally was either strong or absent; however, the BM of
proximal tubules was weakly labeled for the a5(IV) chain
by MAb A7, while labeling of proximal tubular BM for the
a5(IV) chain by MAb H52 was totally absent. Labeling for
laminin b2 was observed in GBM and Bowman’s capsule
BM, but not in tubular BM. Labeling for laminin b1 was
seen in BM of Bowman’s capsule and all tubules, but not in
GBM. Labeling for laminin g1 was observed in all renal
BM.
The pattern of immunofluorescence staining observed in
kidney from affected dogs was the same in every case, and
labeling for each a(IV) chain was different than that
observed in normal dogs (Table 4). Expression of the
a1-a2(IV) chains in the GBM of affected dogs was in-
creased (Fig. 3B), and labeling for the a1-a2(IV) chains
was also observed in expanded interstitial spaces between
tubules. Labeling for the a3-a4(IV) chains was totally
absent both in the GBM and tubular BM (Figs. 3D, 3F, 4D,
and 4F). Labeling for the a5(IV) chain was observed in
GBM; however, intensity of fluorescence was reduced
compared with that observed in normal dogs (Fig. 3H).
Labeling for the a5(IV) chain was totally absent in the BM
of most tubules, but strong labeling was observed in the BM
of a few tubules that appeared to be collecting tubules (Fig.
4H). In affected dogs, labeling for a5(IV) chains in tubular
BM by both MAb A7 and MAb H52 was always the same.
The weak labeling of proximal tubular BM by Mab A7 seen
in normal dogs was not observed in affected dogs. Labeling
Table 4. Relative distribution of a(IV) chains in renal and epidermal basement membranes of English cocker spaniel dogs with hereditary
nephritis
GBM Bowman’s capsule
Distal tubular Epidermal
basement membrane
Normal, HN-unaffected, and HN-carrier dogsa
a1-a2(IV) 1 11 11 1
a3-a4(IV) 11 2 11 2
a5(IV) 11 1 11 11
a6(IV) Variablec 1 1 (CT) 11
HN-affected dogsb
a1-a2(IV) 11 11 11 1
a3-a4(IV) 2 2 2 2
a5(IV) 1 1 1 (CT) 11
a6(IV) 1 1 1 (CT) 11
Abbreviations are: HN, hereditary nephritis; BM, basement membrane; CT, positive (1) labeling of BM in occasional tubules that appeared to be
collecting tubules.
a Dog nos. 12–16; N 5 5
b Dog nos. 3–5, 7–10; N 5 7
c Labeling of GBM was variable. In adolescent dogs, labeling was absent; however, positive (1) labeling was observed in dogs that were 30 months
of age or older. Labeling was segmental in 2 dogs and diffuse in 2 others.
Fig. 3. Immunofluorescence staining for collagen IV chains in glomeruli of normal dogs (A, C, E, and G) and affected dogs (B, D, F, and H). (A and
B) Comparison of labeling for a1(IV) chains in normal and affected dogs showing increased labeling of the thickened glomerular basement membrane
(GBM) in the affected dog. (C and D) Comparison of labeling for a3(IV) chains in normal and affected dogs showing total absence of labeling in the
affected dog. (E and F) Comparison of labeling for a4(IV) chains in normal and affected dogs showing total absence of labeling in the affected dog.
(G and H) Comparison of labeling for a5(IV) chains in normal and affected dogs showing that labeling is present but reduced in the GBM of the affected
dog.
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for the a5(IV) chain was observed in BM of Bowman’s
capsule of affected dogs (Fig. 3H), as well as in the walls of
their renal arterioles (not shown). Intensity of fluorescence
labeling for the a5(IV) chain in these sites was similar to
that observed in normal dogs. Additionally, GBM labeling
for the a6(IV) chain was observed in all affected dogs (Fig.
5D). The a6(IV) chain was co-expressed with the a5(IV)
chain in the BM of Bowman’s capsule (Fig. 5D), in
collecting tubular BM (Fig. 5E), and in walls of renal
arterioles (not shown). Except for observation of increased
labeling for laminin g1 in expanded interstitial spaces
between tubules, labeling for all the laminins examined was
the same in affected dogs as was observed in normal dogs.
Skin specimens. In normal dogs, labeling for a1-a2(IV)
chains and for a5-a6(IV) chains was observed in epidermal
BM, and labeling for a3-a4(IV) chains was totally absent
(Table 4). In skin specimens from affected dogs, labeling
for a1-a2(IV) chains (Fig. 5H) and for a5-a6(IV) chains
(Fig. 5 F, G) was observed in the epidermal BM, with the
intensity of fluorescence labeling the same as that seen in
normal dogs.
DISCUSSION
We studied a progressive nephropathy that caused pro-
teinuria and juvenile-onset chronic renal failure in 10 ECS
dogs. The clinical and histological features of the kidney
disease in these dogs were identical to those of the inher-
ited nephropathy described previously in this breed [21–
26]. Some of the dogs we studied were siblings, and disease
occurrence in their families was consistent with autosomal
recessive transmission, which is the reported mode of
inheritance for familial nephropathy in ECS dogs [27].
Pedigrees of all affected dogs showed that they had some
ancestors in common, but this is probably true of many ECS
dogs in North America, regardless of their health status.
Because of this common ancestry, it is likely that the
causative gene mutation is identical by descent in all ECS
dogs with this inherited renal disease.
Based on their ultrastructural GBM abnormalities and
immunohistochemical features, the ECS dogs we studied
were shown to have a form of HN, which we compared with
other forms of HN reported in dogs and with AS in
humans. Although hematuria was observed much more
often in affected than in unaffected ECS dogs, hematuria
was not as prominent a finding in the affected dogs as was
proteinuria. Fewer than half of the specimens obtained
from affected dogs showed hematuria, which was always
mild, but all affected dogs exhibited persistent proteinuria,
which was substantial. Autosomal recessive HN in ECS
dogs is thus similar to all previously reported forms of
canine HN in that proteinuria rather than hematuria is the
principal abnormality of the urine in affected dogs [15, 18,
45]. Additionally, certain transgenic COL4A3 mutant mice
have proteinuria without hematuria [33], and humans with
AS typically have persistent microscopic hematuria without
proteinuria [1–3]. However, proteinuria eventually devel-
ops as the disease progresses, and correlation between the
percent of GBM with lamina densa splitting and degree of
proteinuria has been reported in patients with AS [46].
The clinicopathologic progression and severity of HN in
affected male and female ECS dogs was similar, as ex-
pected for an autosomal recessive disease. Prior descrip-
tions of familial nephropathy in ECS dogs state that the
onset of illness usually occurs at 6 to 24 months of age, and
the dogs we studied were euthanatized at 8 to 27 months of
age. Thus, affected ECS dogs appear to survive somewhat
longer than affected male Samoyed dogs with X-linked HN,
which usually progress to terminal renal failure by 8 to 15
months of age [12, 15], but not so long as many bull terriers
with autosomal dominant HN, which are reported to be a
few months to 10 years old when death occurs [18]. In
humans with AS, the rate of progression to end-stage renal
disease also has significant interkindred variability, but
X-linked Alport families are fairly cleanly divided into
those in which the mean age of onset for end-stage renal
disease in affected males is less or greater than 30 years [3].
Among dogs with HN, the rates of disease progression in
male Samoyeds with X-linked disease and in ECS dogs with
autosomal recessive HN are analogous to that observed in
the subset of Alport patients who usually develop end-stage
renal disease before the end of their third decade of life.
Our evaluations of ECS dogs with autosomal recessive
HN did not detect extrarenal abnormalities similar to those
reported in humans with AS. The dogs did not have hearing
deficits, ocular lesions or hematologic defects that seemed
analogous to the entities that have been associated with the
nephropathy in Alport patients. Such abnormalities gener-
ally have not been observed in dogs with other forms of
HN; however, anterior lenticonus was reported in bull
terriers with the autosomal dominant form [18].
The ultrastructural appearance of GBM in ECS dogs
with autosomal recessive HN was identical to that seen in
other forms of canine HN and in human AS. In studies of
affected male Samoyed dogs with X-linked HN, electron
microscopy demonstrated foci of bilaminar splitting of the
GBM at one month of age, before the onset of proteinuria
Fig. 4. Immunofluorescence staining for collagen IV chains in renal tubules of normal dogs (A, C, E, and G) and affected dogs (B, D, F, and H). (A
and B) Comparison of labeling for a1(IV) chains in tubular basement membrane (BM) of normal and affected dogs. In the affected dog, labeling also
is observed in the expanded interstitial spaces between tubules. (C and D) Comparison of labeling for a3(IV) chains in tubular BM of normal and
affected dogs showing total absence of labeling in the affected dog. (E and F) Comparison of labeling for a4(IV) chains in tubular BM of normal and
affected dogs showing total absence of labeling in the affected dog. (G and H) Comparison of labeling for a5(IV) chains in tubular BM of normal and
affected dogs showing labeling of the BM of occasional tubules that appear to be collecting tubules in the affected dog.
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[13]. Subsequently, abnormal areas of GBM became mul-
tilaminar and confluent by three to four months of age, at
which time proteinuria was persistent. In this study of ECS
dogs with autosomal recessive HN, GBM ultrastructure
was examined only in disease stages occurring after the
development of persistent proteinuria. At the earliest stage
examined, GBM alterations were diffuse and the predom-
inant change was an irregular degree of bilaminar splitting
and mild thickening, but some areas where the GBM
appeared thinned were observed as well. Progressively
greater degrees of thickening and multilamellation of the
GBM were found at later stages of the disease.
With the X-linked form of HN in Samoyed dogs, carrier
females develop proteinuria at the same age as affected
males [15, 16]. In such carrier females, electron microscopy
reveals a mixture of GBM with multilaminar splitting and
GBM with normal ultrastructure [13]. In contrast with the
abnormalities exhibited by carrier female Samoyeds with
X-linked HN, the clinical findings and ultrastructural ap-
pearance of the GBM in obligate ECS dog carriers of
autosomal recessive HN were normal. Transgenic mice
heterozygous for COL4A3 mutations also display no de-
tectable abnormalities [33, 34].
Distribution of a(IV) chain expression observed in BMs
of kidney from normal ECS dogs was similar to that found
in normal humans [28, 39, 40, 47–49], however, several
differences were observed. One minor difference was that
the a3-a4(IV) chains were not expressed in the Bowman’s
capsule of ECS dogs, whereas these chains normally are
expressed in portions of Bowman’s capsule (that is, near
the vascular pole) of humans. Absence of the a3(IV) chain
in dog Bowman’s capsule has been noted previously [18]. A
more striking difference was that the a6(IV) chain was
expressed in the GBM of normal adult ECS dogs. In
normal human kidneys, the a6(IV) chain is not expressed
in GBM [48, 49]. Additionally, the a6(IV) chain was not
expressed in distal tubular BM of normal ECS dogs,
whereas this chain normally is expressed in distal tubular
BM of humans. Finally, expression of a5(IV) and a6(IV)
chains was observed in the walls of renal arterioles of
normal ECS dogs, but these chains are not expressed in the
walls of renal arterioles of humans.
The probe, B66, that we used for immunofluorescence
staining of the a6(IV) chain is a specific anti-peptide
antibody raised against bovine a6(IV) using previously
described methods [44]. The distribution of renal B66
labeling was different than that observed for antibodies that
reacted with each of the other a(IV) chains. Compared
with staining by antibodies for the a1-a2(IV) chains, a lack
of B66 labeling was observed in GBM of adolescent normal
dogs as well as in proximal and distal tubular BM of all
normal and affected dogs. Compared with staining by
antibodies for the a3-a4-a5(IV) chains, a lack of B66
labeling was observed in GBM of adolescent normal dogs
and in distal tubular BM of all normal dogs. Additionally,
B66 stained Bowman’s capsule and epidermal BM of all
normal and affected dogs, but antibodies for a3-a4(IV)
chains did not react with these structures in any dog.
Complete absence of labeling for a3(IV) and a4(IV)
chains in kidney of affected ECS dogs is consistent with the
autosomal recessive mode of disease transmission in this
breed, and is identical to findings in humans and mice with
autosomal recessive AS [32–34]. The COL4A3 and
COL4A4 genes presumably are located on an autosome in
dogs as they are in humans and all other species studied to
date. The finding of labeling for a5(IV) chains in affected
ECS dogs at sites where a5(IV) chains are not normally
co-expressed with a3(IV) and a4(IV) chains (that is, in
Bowman’s capsule and epidermal BM), together with ob-
servation of similar disease frequency and severity in males
and females, suggests that the COL4A5 gene is not mu-
tated in these dogs. From the outset of our investigations of
autosomal recessive HN in ECS dogs, we have theorized
that the causative gene mutation would involve either the
COL4A3 or the COL4A4 locus [19], and results of this
study further support that hypothesis.
Diffuse linear labeling for a1-a2(IV) chains, the a5(IV)
chain, and the a6(IV) chain was observed in the thickened
GBM of every affected dog examined. Presence of the
a5(IV) chain in GBM of affected dogs was confirmed with
two specific antibodies. Compared with the intensity of
staining observed in the GBM of normal and obligate
carrier ECS dogs, relative expression of the a5(IV) chain in
GBM of affected dogs was markedly decreased and that of
a1-a2(IV) chains and the a6(IV) chain was increased. A
similar increase in expression of a1-a2(IV) chains has been
observed previously in GBM of humans with X-linked AS
[30], autosomal recessive AS [32] and COL4A3 mutant
mice [33]. In humans with autosomal recessive AS, how-
ever, expression of the a5(IV) chain has not been observed
in GBM that lacked expression of a3-a4(IV) chains. Our
findings suggest that in dog GBM a5(IV) chains can be
expressed in the absence of a3(IV) and a4(IV) chains.
Glomerular cells that produce GBM also appear to be
Fig. 5. Immunofluorescence staining for collagen IV chains in glomeruli of normal dogs (A, B, and C) and in kidney (D and E) and skin (F, G, and
H) of affected dogs. (A, B and C) Examples of the variable labeling for a6(IV) chains in glomerular basement membrane (GBM) observed in normal
dogs. Adolescent dogs lack expression of the a6(IV) chain in their GBM (A), but older dogs have segmental (B) or diffuse linear (C) GBM labeling.
Bowman’s capsule is labeled in all cases. (D) Labeling for a6(IV) chains in GBM and Bowman’s capsule of an affected dog. (E) Labeling for the a6(IV)
chain in tubular BM showing labeling of occasional tubules that appear to be collecting tubules in an affected dog. (F) Labeling for the a6(IV) chain
in epidermal BM of an affected dog. (G) Labeling for the a5(IV) chain in epidermal BM of an affected dog. (H) Labeling for the a1(IV) chain in
epidermal BM of an affected dog. Intensity of epidermal BM labeling for collagen IV chains in affected dogs (panels F, G, and H) is the same as
observed in normal dogs (not shown).
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capable of expressing a6(IV) chains as long as the a5(IV)
chains are present, at least in ECS dogs. Our observations
also suggest that an absence of a3(IV) and a4(IV) chains is
sufficient to trigger the processes that cause multilamella-
tion of the GBM to develop in dogs with HN.
Diagnosis of autosomal recessive HN in ECS dogs can be
supported by demonstration of absent a3-a4(IV) chain
expression in kidney specimens; however, affected ECS
dogs cannot be identified by immunohistochemical evalua-
tion of their skin because a3-a4(IV) chains are not nor-
mally expressed in epidermal BM of dogs. Additionally,
a(IV) chain expression in the kidney of obligate ECS dog
carriers of HN is similar to that observed in normal dogs.
Therefore, immunohistochemical evaluations are not use-
ful for identification of HN-carriers in the ECS dog popu-
lation.
In Samoyed dogs with X-linked HN, evidence of de-
creased expression of the a3-a4-a5(IV) chains in the
kidney of affected males has been demonstrated at the
message and protein levels [50]. Among reported autoso-
mal models of AS in dogs, however, HN in ECS dogs is the
first disorder in which abnormal renal expression of a3-
a5(IV) chains has been demonstrated. In bull terriers with
autosomal dominant HN, expression of a3(IV) and a5(IV)
chains appeared to be normal by immunohistochemical
evaluation [18]. Animal models of autosomal recessive AS
have been generated in mutant mice [33, 34] but ECS dogs
with HN are the only naturally occurring animal model of
autosomal recessive AS yet described. Further investigation
of this model may provide insights regarding the pathogen-
esis of ultrastructural GBM lesions in AS, because affected
ECS dogs have typical thickening and multilamellation of
GBM that contains a1(IV), a2(IV), a5(IV) and a6(IV)
chains.
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